Tandem糖尿病护理 TNDM 深 沪
等待开盘 08-15 09:30:00 美东时间
10.66
-0.470
-4.22%
华盛通- 最 高11.26
- 今 开11.17
- 成交量 205.95万股
- 最 低 10.635
- 昨 收 11.13
- 总市值 7.10亿
- 52周最高 47.60
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 9.98
- 委 比 58.82%
- 总股本 6660.72万
- 历史最高 302.50
- 量 比 0.39
- 振 幅 5.62%
- 历史最低 2.14
- 每 手 1
- 风险率 9.99%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | DoorDash获上调目标价从230美元升至300美元； 摩根大通上调Shopify目标价从115美元升至179美元
今日重点评级关注：HC Wainwright & Co.：维持FibroGen"买入"评级，目标价从10美元升至43美元；摩根大通：维持Cogent Biosciences"超配"评级，目标价从29美元升至30美元
08-08 09:34
Tandem Diabetes Care shares are trading lower after the company reported mixed Q2 financial results and narrowed its FY25 sales guidance below estimates.
Tandem Diabetes Care shares are trading lower after the company reported mixed ...
08-07 05:41
Tandem Diabetes Care Narrows FY2025 Sales Guidance from $997.000M-$1.007B to $1.000B vs $1.004B Est
Tandem Diabetes Care (NASDAQ:TNDM) narrows FY2025 sales outlook from $997.000 million-$1.007 billion to $1.000 billion vs $1.004 billion estimate.
08-07 04:26
Earnings Scheduled For August 6, 2025
Companies Reporting Before The Bell • Lineage (NASDAQ:LINE) is likely to report...
08-06 16:33
Citigroup Downgrades Tandem Diabetes Care to Sell, Lowers Price Target to $14
Citigroup analyst Joanne Wuensch downgrades Tandem Diabetes Care (NASDAQ:TNDM) from Neutral to Sell and lowers the price target from $24 to $14.
07-09 20:07
Shares of glucose monitor and insulin pump stocks are trading lower after the CMS proposed that continuous glucose monitors and insulin infusion pumps be reclassified under the frequent and substantial servicing payment category.
Shares of glucose monitor and insulin pump stocks are trading lower after the C...
07-02 01:54
Watching Stocks Involved In Wearable Health Devices; Traders Circulate X Post Saying "RFK says HHS about to launch one of the biggest campaigns in HHS history to encourage Americans to use wearable health devices (like CGMs). his vision is every American wearing "wearable" in 4 years... HUGE COIs here with some of his top advisors & their businesses."
https://x.com/SarahKarlin/status/1937539272392733011
06-25 00:08
美股大行评级 | 潜在涨幅40%！华兴资本首予Coinbase买入评级，目标价353.3！Sarepta治疗遭多家机构下调评级和目标价！
美股大行评级 | 潜在涨幅40%！华兴资本首予Coinbase买入评级，目标价353.3！Sarepta治疗遭多家机构下调评级和目标价！
06-18 09:46
美股大行评级 | 超配！Hinge Health获多家大行首予评级； Oppenheimer上调Mate目标价从665美元升至775美元
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1141651881139785729.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• Ascendiant Capital：维持SurgePays Inc(SURG)"买入"评级，目标价从8.75美元升至9美元</p> <p>• Ascendiant Capital：维持LiqTech Internatio
06-17 09:46
Truist bullish on diabetes companies citing potential market growth
Truist initiated coverage of diabetes care firms DexCom (NASDAQ:DXCM), and Insulet (NASDAQ:PODD) at buy, and Tandem Diabetes Care (NASDAQ:TNDM) at hold, citing potential market growth and feedback fro...
06-16 23:24
